Abiopharma

🔍 Huang Ming-Chia (Director)

Company: MKDWELL Tech Inc. (MKDW)

Report Date: 2026-07-17

Detailed Transactions and Holdings:

• Acquired 26,000,000 shares of Ordinary Shares (Direct)
  Date: 2026-07-17 | Code: P | equity_swap_involved: 0 | shares_owned_after: 26,340,340.00 | transaction_form_type: 4

Footnotes:

• REMARKS: On July 17, 2026, 20 shareholders (the "Concert Shareholders") holding an aggregated of 26,000,000 ordinary shares entered into the deed of confirmation of acting in concert ("Deed of AIC") with Ming-Chia Huang, which confirm that the Concert Shareholders shall act in concert with and follow the lead and directions of Mr. Huang in respect of the Company so as to support the stability and continuity of the control of the Company. The Concert Shareholders shall exercise all voting rights attaching to the shares in accordance with the directions and lead of Mr. Huang and consult with Mr. Huang and follow his instructions prior to voting on any resolution of the Company. The Concert Shareholders shall not exercise any voting rights in any manner inconsistent with the directions of Mr. Huang. Mr. Huang does not have dispositive power over the shares owned by the Concert Shareholders. Subsequent to the transaction, Mr. Huang is interested in (i) 65,974 ordinary shares and 274,366 Class A preferred shares which are directly held by himself; and (ii) 26,000,000 ordinary shares owned by the Concert Shareholders pursuant to the Deed of AIC.